UK markets close in 1 hour 46 minutes
  • FTSE 100

    6,394.95
    -37.22 (-0.58%)
     
  • FTSE 250

    19,637.47
    -152.09 (-0.77%)
     
  • AIM

    1,033.33
    +1.57 (+0.15%)
     
  • GBP/EUR

    1.1209
    -0.0021 (-0.19%)
     
  • GBP/USD

    1.3349
    -0.0010 (-0.07%)
     
  • BTC-GBP

    14,375.10
    -42.94 (-0.30%)
     
  • CMC Crypto 200

    380.22
    +9.70 (+2.62%)
     
  • S&P 500

    3,628.78
    -6.63 (-0.18%)
     
  • DOW

    29,939.92
    -106.32 (-0.35%)
     
  • CRUDE OIL

    45.58
    +0.67 (+1.49%)
     
  • GOLD FUTURES

    1,811.70
    +7.10 (+0.39%)
     
  • NIKKEI 225

    26,296.86
    +131.27 (+0.50%)
     
  • HANG SENG

    26,669.75
    +81.55 (+0.31%)
     
  • DAX

    13,269.15
    -23.29 (-0.18%)
     
  • CAC 40

    5,553.67
    -4.75 (-0.09%)
     

H&R GmbH & Co. KGaA publishes Quarterly Statement for third quarter of 2020

·5-min read

DGAP-News: H&R GmbH & Co. KGaA / Key word(s): 9 Month figures/Quarterly / Interim Statement
13.11.2020 / 11:11
The issuer is solely responsible for the content of this announcement.

Press Release

H&R GmbH & Co. KGaA: Quarterly statement for third quarter of 2020

- Recovery continued in third quarter of 2020

- EBITDA with EUR 14.1 million significantly above previous year

- Earnings projections of up to EUR 45.0 million confirmed

Salzbergen, November 13, 2020. H&R GmbH & Co. KGaA (abbrev.: H&R KGaA; ISIN DE000A2E4T77) has confirmed its preliminary revenue and earnings figures for the third quarter of 2020: Between July and September 2020 the company achieved a consolidated operating income (EBITDA - consolidated income before tax, other financial income and expenses and depreciation/amortization, impairment and appreciation of fixed assets and property, plant and equipment ) of EUR 14.1 million (Q3-2019: EUR 5.1 million.). It not only significantly exceeded the same quarter of the previous year, but also marked the strongest contribution to operating earnings in 2020. EBIT closed at EUR 1.9 million after last year's EUR -6.5 million. Earnings before taxes (EBT) in the third quarter of 2020 were almost balanced at EUR -0.1 Million (Q3-2019: EUR -8.4 million), the company closed the net income attributable to shareholders with EUR -1.2 million (Q3-2019: EUR -6.0 million). Sales revenues in the third quarter of the current financial year fell to EUR 208.1 million (Q3-2019: EUR 274.7 million), in particular due to purchase quantities that increased during the current year but did not reach previous years' figures.

Overview of main key figures:

 

For the full year H&R currently expects an achievable EBITDA of up to EUR 45.0 million.

For further statements on the trends in business performance and earnings, the company refers to the quarterly report for the third statement of 2020, published today, which is available for download at www.hur.com in the "Investor Relations" section.

Contact information:
H&R GmbH & Co. KGaA, Head of Investor Relations/Communications, Ties Kaiser
Neuenkirchener Strasse 8, 48499 Salzbergen
Phone.: +49 40 43218-321, Fax: +49 40 43218-390
Email: ties.kaiser@hur.com ; www.hur.com

H&R GmbH & Co. KGaA:
H&R KGaA is a specialty-chemicals company listed on the Frankfurt Stock Exchange's Prime Standard segment. It develops and manufactures crude-oil-based chemical and pharmaceutical specialty products and produces high-precision plastic parts.

Forward-looking statements and forecasts:
This press release contains forward-looking statements. The statements are based on the current estimates and forecasts by the Executive Board and the information available to the Board at this time. These forward-looking statements do not provide any warranty for the future developments and results contained therein. The future developments and results are dependent on a number of factors; they entail various risks and contingencies and are based on assumptions which could prove to be incorrect. We do not assume any responsibility for updating the forward-looking statements contained in this press release.


13.11.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

in million EUR

9 months 2020

9 months 2019

Diff. absolute

Sales Revenues

649.9

824.7

-174.8

ChemPharm REFINING

397.5

513.8

-116.3

ChemPharm SALES

229.5

285.4

-55.9

PLASTICS

29.2

32.9

-3.7

Consolidation

-6.4

-7.4

1.0

 

 

 

 

Consolidated Operative Income (EBITDA)

30.7

44.8

-14.1

ChemPharm REFINING

15.7

27.0

-11.3

ChemPharm SALES

17.8

22.5

-4.7

PLASTICS

0.2

-5.4

5.6

Consolidation

-3.0

0.7

-3.7

 

 

 

 

EBIT

-6.8

11.4

-18.2

EBT

-12.8

5.6

-18.4

Net income attributable to shareholders

-14.8

4.1

-18.9

Earnings per share (EUR)

-0.40

0.11

-0.51

Operative Cashflow

44.6

71.1

-26.5

Free Cashflow

14.4

24.6

-10.2

 

Q3-2020

Q3-2019

Diff. absolute

Sales Revenues

208.1

274.7

-66.6

ChemPharm REFINING

120.6

168.4

-47.8

ChemPharm SALES

78.6

97.4

-18.8

PLASTICS

11.0

10.9

0.1

Consolidation

-2.1

-2.1

0.0

 

 

 

 

Consolidated operative income (EBITDA)

14.1

5.1

9.0

ChemPharm REFINING

8.7

4.1

4.6

ChemPharm SALES

6.5

7.3

-0.8

PLASTICS

0.4

-5.0

5.4

Consolidation

-1.4

-1.3

-0.1

 

 

 

 

EBIT

1.9

-6.5

8.4

EBT

-0.1

-8.4

8.3

Net income attributable to shareholders

-1.2

-6.0

4.8

Earnings per share (EUR)

-0.03

-0.16

0.13

Operative cashflow

5.2

20.0

-14.8

Free cashflow

0.8

3.7

-2.9

 

30/9/2020

31/12/2019

Diff. absolute

Balance sheet total

765.7

838.6

-72.9

Equity

338.5

363.4

-24.9

Equity ratio (%)

44.2

43.3

0.9

in million EUR

9 months 2020

9 months 2019

Diff. absolute

Sales Revenues

649.9

824.7

-174.8

ChemPharm REFINING

397.5

513.8

-116.3

ChemPharm SALES

229.5

285.4

-55.9

PLASTICS

29.2

32.9

-3.7

Consolidation

-6.4

-7.4

1.0

 

 

 

 

Consolidated Operative Income (EBITDA)

30.7

44.8

-14.1

ChemPharm REFINING

15.7

27.0

-11.3

ChemPharm SALES

17.8

22.5

-4.7

PLASTICS

0.2

-5.4

5.6

Consolidation

-3.0

0.7

-3.7

 

 

 

 

EBIT

-6.8

11.4

-18.2

EBT

-12.8

5.6

-18.4

Net income attributable to shareholders

-14.8

4.1

-18.9

Earnings per share (EUR)

-0.40

0.11

-0.51

Operative Cashflow

44.6

71.1

-26.5

Free Cashflow

14.4

24.6

-10.2

 

Q3-2020

Q3-2019

Diff. absolute

Sales Revenues

208.1

274.7

-66.6

ChemPharm REFINING

120.6

168.4

-47.8

ChemPharm SALES

78.6

97.4

-18.8

PLASTICS

11.0

10.9

0.1

Consolidation

-2.1

-2.1

0.0

 

 

 

 

Consolidated operative income (EBITDA)

14.1

5.1

9.0

ChemPharm REFINING

8.7

4.1

4.6

ChemPharm SALES

6.5

7.3

-0.8

PLASTICS

0.4

-5.0

5.4

Consolidation

-1.4

-1.3

-0.1

 

 

 

 

EBIT

1.9

-6.5

8.4

EBT

-0.1

-8.4

8.3

Net income attributable to shareholders

-1.2

-6.0

4.8

Earnings per share (EUR)

-0.03

-0.16

0.13

Operative cashflow

5.2

20.0

-14.8

Free cashflow

0.8

3.7

-2.9

 

30/9/2020

31/12/2019

Diff. absolute

Balance sheet total

765.7

838.6

-72.9

Equity

338.5

363.4

-24.9

Equity ratio (%)

44.2

43.3

0.9

Language:

English

Company:

H&R GmbH & Co. KGaA

Neuenkirchener Str. 8

48499 Salzbergen

Germany

Phone:

+49 (0)40 43 218 321

Fax:

+49 (0)40 43 218 390

E-mail:

investor.relations@hur.com

Internet:

www.hur.com

ISIN:

DE000A2E4T77

WKN:

A2E4T7

Listed:

Regulated Market in Dusseldorf, Frankfurt (Prime Standard), Hamburg; Regulated Unofficial Market in Berlin, Hanover, Munich, Stuttgart, Tradegate Exchange

EQS News ID:

1147870


 

End of News

DGAP News Service

show this
show this